UMM logo

A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

Share

Email PageEmail Print PagePrint
Loading

Maryland Heart Center

Fellow Research

Fellows in Cardiovascular Disease are expected to participate in scholarly effort as part of their training. Towards this end, we provide six months of protected research time as a minimum, and we provide faculty mentorship in guidance of this experience. The six months generally occur in two blocks of three months. Fellows are expected to identify a faculty mentor at the end of their first year of fellowship training and are asked to work with that mentor towards identification of a scholarly project with concrete goals and objectives.

After the first three months there is an interval evaluation to assure that appropriate milestones are being met. There is substantial support for research methodology and statistical analysis within the Division and the School of Medicine. Fellows are expected to present their scholarly effort to their peers and the faculty at Cardiology Grand Rounds. Dr. Christopher deFilippi has recently been appointed to head this effort of Fellow research activity. Our fellows have been very successful in these scholarly activities. Listed below is a sample of our collective fellow bibliography.

Each year, at our end of year banquet, we honor one fellow with an award for outstanding scholarship, named for one of our prior faculty members, Dr. Nathan H. Carliner. A plaque resides within the Division of Cardiology commemorating this event.

Recent Fellow Bibliography

  1. Adlin EV, Blome SE, Lender D. Endocrine and Metabolic Diseases. In Wolfsthal SD (ed.) NMSMedicine. Lippincott, Williams and Wilkens, Baltimore, MD, 2008.

  2. Mackowiak PA, Blome SE, Knodell, RG. A 70 Year Old Woman With Abdominal Pain. Am J Med Sci. 2008; 335(3):205-208.

  3. Talwani R, Blome SE. A 40 Year Old Woman With Headache. Am J Med Sci. 2008; 336(5): 418-422.

  4. Miller, M, Rhyne J, Chen H, Beach V, Ericson R, Luthra K, Dwivedi M and Misra A. “APOC3 Promoter Polymorphisms C-482T and T-455C Are Associated with the Metabolic Syndrome.” Archives of Medical Research. 2007(38):444-451.

  5. Weld ED, Bizzell KR, Katzen SM, Rogstad AS, Gold BS. Acute Takotsubo Cardiomyopathy in the Setting of Grave’s Disease. Presented at the Regional Meeting of the Maryland Chapter of the American College of Physicians, Baltimore, MD, May 2008.

  6. Gottlieb SS, Kop WJ, Thomas SA, Katzen SM, Vesely MR, Greenberg N, Marshall J, Cines M, Minshall S. A Double-Blind Placebo-Controlled Pilot Study of Controlled-Release Paroxetine on Depression and Quality of Life in Chronic Heart Failure. Am Heart J. 153(5): 868-873, 2007.

  7. Majeed F, Kop W, Poston R, Kallam S, Mehra MR. Antiplatelet and Coagulation Biomarkers as Predictors of Clinical Thromboembolic Events following Permanent Mechanical Circulatory Support. Nature Clinical Practice Cardiovascular Medicine. Manuscript Accepted. In Press 2009.

  8. Majeed F, Miller M. Low High-Density Lipoprotein Cholesterol: An Important Consideration in Coronary Heart Disease Risk Assessment. Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2): 175-81.

  9. Majeed F, Miller M. Can intense exercise contribute to cardiovascular disease? Future Cardiology. 2007 May;3(3):239-42.

  10. Majeed F, Kelemen MD. Acute coronary syndromes in the elderly. Clin Geriatr Med. 2007 May; 23(2):425-40.

  11. Goel R, Majeed F, Vogel R, Corretti MC, Weir M, Mangano C, White C, Plotnick GD, Miller M. Exercise-induced hypertension, endothelial dysfunction and coronary artery disease in a marathon runner. Am J Cardiol. 2007 Mar 1;99(5):743-4.

  12. Schwartz DJ, Kop WJ, Park MH, Vesely MR, Li S, Mehra MR, Gottdiener JS. Interventricular Dyssynchrony in Pulmonary Arterial Hypertension: Evidence for Early Right Ventricular and Septal Mechanical Activation [Abstract]. 4th World Symposium of Pulmonary Hypertension. 2008

  13. Sailey C, Alexiev B, Gammie J, Pinell-Salles P et al. Crystal storing histiocytosis as a cause of symptomatic cardiac mass. Archives of Pathology. Accepted for publication.

  14. Bloeden LT, Dunbar RL, Duffy D, Pinell-Salles P et al. Safety, pharmacokinetics and pharmacodynamics of a single dose of oral apolipoprotein A-I mimetic peptide D-4F in high-risk cardiovascular patients. Journal of Lipid Research 2008;49(6):1344-52.

  15. Gandotra P, Miller M. The role of triglycerides in cardiovascular risk. Current Cardiology Reports. 2008. Nov;10(6):505-11.

  16. Roberts, BD, Shorofsky SS et al. Increased defibrillation thresholds in patients with hypertrophic cardiomyopathy. Abstract submitted, pending acceptance to Heart Rhythm Society Scientific Sessions, 5/2009.

  17. Rogers J, Robinson S, Khanna A, McCulle S, Blome S, Bassi A, Xu J, Shorofsky S, Mehra M. Transforming Growth Factor-ß Polymorphisms and Prediction of Clinical Outcome With Prophylactic Defibrillator Implantation in Chronic Heart Failure. Circulation, Oct 2007; 116: II_635.

  18. Rogers J, Zakaria S, Thom K, Flammer K, Kanno M, Mehra M. Immune Reconstitution Inflammatory Syndrome and Human Immunodeficiency Virus–Associated Myocarditis. Mayo Clin Proc. 2008;83:1275-1279

  19. Shah KB, Duda MK, O’Shea KM, Chess DJ, Khairallah RJ, Frayne-Robillard I, Kop WJ, Des Rosiers R, Stanley WC. High fat composition inhibits the cardioprotective effects of ω-3 polyunsaturated fatty acids on ventricular hypertrophy. Manuscript pending

  20. Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S,Hansen K, deFilippi CR. Interpreting follow-up NT-proBNP concentrations and symptoms after hospitalization for acute dyspnea. Manuscript pending.

  21. Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S,Hansen K, Li S, deFilippi CR. Natriuretic peptide and echocardiography in unselected acute dyspnea patients: implication of elevated levels with normal systolic function. Submitted for publication.

  22. Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S,Hansen K, Mehra MR, deFilippi CR. Lack of diagnostic and prognostic utility of circulating serum myeloperoxidase levels in patients presenting with dyspnea. Clin Chem. 2009;55(1):59-67.

  23. Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanholtz CH, Mehra MR, Gottlieb SS. The characteristics and prognostic importance NT-ProBNP concentrations in critically ill patients. Am J Med.2007; 120(12):1071-7.

  24. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006; 166 (17):1805-13.

Please call if you would like to make an appointment or talk to someone about our services. Patients dial 1-866-408-6885, physicians dial 410-328-6622 or 1-800-318-1019.